Bismacine, also known as Chromacine, is a substance manufactured by American Biologics Corporation and marketed as a purported alternative treatment for Lyme disease. Bismacine contains high levels of bismuth, and two deaths are recorded following the use of intravenous bismacine to treat Lyme disease. In 2006, the U.S. Food and Drug Administration warned consumers not to use bismacine, noting that it is ineffective and dangerous.
- Quirk M. (2006). "Alternative health therapy for Lyme disease results in death". Lancet Infect Dis 6 (8): 546. doi:10.1016/S1473-3099(06)70563-1.
- "FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine". U.S. Food and Drug Administration. 2006-06-21. Retrieved 2008-10-16.
|This article about alternative medicine is a stub. You can help Wikipedia by expanding it.|